To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Opko's Rayaldee

FDA approved an NDA from Opko Health Inc. (NYSE:OPK;

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE